Hangzhou Yuanda Biopharmaceutical R&D strength (tech talent demand and pay)

What is the demand for tech talent at Hangzhou Yuanda Biopharmaceutical? Based on job postings in the past year, “医疗卫生/美容保健类”占24.1%,“计算机/网络/技术类”占14.3%,“生物/制药/化工/环保类”占3.3%,“其他(研发和技术类)”占1.9%,“科研类”占1.8%,“咨询/顾问类”占1.1%,“机械/仪器仪表类”占0.3%,“电气/能源/动力类”占0.2%,“电子/电器/通信技术类”占0.1%,“美术/设计/创意类”占0.1%. For reference only.

Master's degree job demand analysis at Hangzhou Yuanda Biopharmaceutical (More)

?
Growth rate
2026 vs 2025
  • 2025: Up 1200%
  • 2024: Down 75%
  • 2023: Up 9%
  • 2022: Down 31%
Hangzhou Yuanda Biopharmaceutical master's hiring over the years:
* Hiring volume was generally low in 2020-2022 due to the pandemic

PhD job demand analysis at Hangzhou Yuanda Biopharmaceutical (More)

N/A
Growth rate
Hangzhou Yuanda Biopharmaceutical PhD hiring over the years:
* Hiring volume was generally low in 2020-2022 due to the pandemic

Hangzhou Yuanda Biopharmaceutical honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

People who follow Hangzhou Yuanda Biopharmaceutical also follow

Hangzhou Yuanda Biopharmaceutical Competitors (Similar Companies)

“Mainly engaged in the production and sales of antibiotics, traditional”
“Mainly engaged in the production and sales of antibiotics, traditional”
“Professional services for the entire clinical trial process of drug pr”
“To develop high-quality biologics that are accessible and affordable f”
“Top 10 in China's beverage industry”
“合成生物学技术开发商”
“Precision medicine driven by proteomics”
“一个以“东方彩妆,以花养妆”为理念的彩妆品牌”
“To produce more affordable and effective medicines for the Chinese peo”
“A high-tech enterprise dedicated to the research, development, and ind”
“Continuously innovating to bring patients medicines that significantly”
“Is an innovative filtration enterprise, focusing on the development an”
“Research, development, and production of anti-tumor and surgical medic”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“A technology-driven international pharmaceutical enterprise”